Award
NIH Reporter #1P50HD123367-01
In vitro, ex vivo and in vivo Efficacy Core
Recipient
WEILL MEDICAL COLL OF CORNELL UNIV
Award Amount
$420,951.00
Ceiling
$420,951.00
Awarded
September 10, 2026
Identifier
1P50HD123367-01
The NIH award supports a Weill Cornell core that evaluates soluble adenylyl cyclase inhibitor compounds as part of research toward an on-demand, nonhormonal male contraceptive.
Description
Funding for the Weill Cornell Medicine Contraception Research Center Technical Core to support assays evaluating the in vitro, ex vivo, and in vivo efficacy of soluble adenylyl cyclase inhibitor compounds and related formulations and metabolites.